Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended					6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) income attributable to Flotek Industries, Inc.	$ (9,561)			$ (14,413)		$ (73,528)	$ 16,449
Less: Income from discontinued operations, net of tax	0			(1,608)		0	44,466
Loss from continuing operations	(9,561)			(12,805)		(73,528)	(28,017)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	468			2,119		2,659	4,379
Amortization of deferred financing costs						0	1,428
Provision for doubtful accounts						474	102
Provision for excess and obsolete inventory						529	0
Impairment of right-of-use assets						7,434	0
Impairment of fixed assets						30,178	0
Impairment of intangible assets						19,842	0
(Gain)/loss on disposal of long-lived assets						(631)	1,093
Non-cash lease expense						242	464
Stock compensation expense						1,521	1,669
Deferred income tax provision						(105)	17,855
Reduction in tax benefit related to share-based awards						0	24
Changes in current assets and liabilities:
Accounts receivable, net						7,252	6,289
Inventories, net						6,418	554
Income taxes receivable						(6,351)	(281)
Other current assets		$ 3,645	$ (4,036)		$ (4,442)	1,715	(1,990)		$ 2,579
Other long-term assets			(3,286)		(3,286)	0	(3,286)		(4,417)
Accounts payable						(10,229)	(4,157)
Accrued liabilities						(16,755)	(10,216)
Income taxes payable						119	1,182
Interest payable						0	(8)
Net cash used in operating activities						(29,216)	(6,344)
Cash flows from investing activities:
Capital expenditures	0			(306)		(42)	(767)
Proceeds from sale of business		3,281			152,217	9,844	152,217	$ 155,498	155,498
Proceeds from sale of assets						66	140
Purchase of JP3, net of cash acquired						(26,284)	0
Purchase of patents and other intangible assets						(8)	(227)
Net cash (used in) provided by investing activities						(16,424)	151,363
Cash flows from financing activities:
Borrowings on revolving credit facility						0	42,984
Repayments on revolving credit facility						0	(92,715)
Proceeds from Paycheck Protection Program loan						4,798
Purchase of treasury stock related to share-based awards						(82)	(142)
Proceeds from sale of common stock						358	0
Payments for finance leases	(14)			(38)		(51)	(38)
Net cash provided by (used in) financing activities						5,023	(49,911)
Discontinued operations:
Net cash used in operating activities						0	(321)
Net cash provided by investing activities						0	337
Net cash flows provided by discontinued operations						0	16
Effect of changes in exchange rates on cash and cash equivalents						(31)	2
Net (decrease) increase in cash and cash equivalents and restricted cash						(40,648)	95,126
Cash and cash equivalents at the beginning of period		100,575	97,509		3,044	100,575	3,044	3,044	3,044
Restricted cash at the beginning of period		663	661		0	663	0	0	0
Cash and cash equivalents and restricted cash at beginning of period		$ 101,238	$ 98,170		$ 3,044	101,238	3,044	$ 3,044	3,044
Cash and cash equivalents at end of period	59,926			97,509		59,926	97,509		100,575
Restricted cash at the end of period	664			661		664	661		663
Cash and cash equivalents and restricted cash at the end of period	$ 60,590			$ 98,170		$ 60,590	$ 98,170		$ 101,238